Gene · 55818
Papers1,506
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,506
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Stochastic Epigenetic Modification and Evolution of Sex Determination in Vertebrates. | J Mol Evol | 2024 | 39565411 | PubTator, text mining | PubMed |
| Impact of Hypoxia and the Levels of Transcription Factor HIF-1α and JMJD1A on Epithelial-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma Cell Lines. | Cancer Genomics Proteomics | 2024 | 39467631 | PubTator, text mining | PubMed |
| Application of large-scale and multicohort plasma proteomics data to discover novel causal proteins in gastric cancer. | Discov Oncol | 2024 | 39422802 | PubTator, text mining | PubMed |
| Identifying prognostic hub genes and key pathways in pediatric adrenocortical tumors through RNA sequencing and Co-expression analysis. | Mol Cell Endocrinol | 2024 | 39413985 | PubTator, text mining | PubMed |
| Post-Translational Modifications of RNA-Modifying Proteins in Cellular Dynamics and Disease Progression. | Adv Sci (Weinh) | 2024 | 39377984 | PubTator, text mining | PubMed |
| β-Adrenergic Signal and Epigenomic Regulatory Process for Adaptive Thermogenesis. | Adv Exp Med Biol | 2024 | 39289284 | PubTator, text mining | PubMed |
| Novel PROTAC probes targeting KDM3 degradation to eliminate colorectal cancer stem cells through inhibition of Wnt/β-catenin signaling. | RSC Med Chem | 2024 | 39281802 | PubTator, text mining | PubMed |
| Histone H3K9 Methylation Features under Hypoxic Conditions after the HIF1A Knockdown in Mesenchymal Stromal Cells In Vitro. | Bull Exp Biol Med | 2024 | 39259464 | PubTator, text mining | PubMed |
| Mechanism and application of feedback loops formed by mechanotransduction and histone modifications. | Genes Dis | 2024 | 39071110 | PubTator, text mining | PubMed |
| KDM3A Ablation Activates Endogenous Retrovirus Expression to Stimulate Antitumor Immunity in Gastric Cancer. | Adv Sci (Weinh) | 2024 | 39031630 | PubTator, text mining | PubMed |
| Stem cell-conditioned medium improves methylation patterns and quality of caprine preantral follicles. | Reproduction | 2024 | 38941180 | PubTator, text mining | PubMed |
| Epigenetic roles of KDM3B and KDM3C in tumorigenesis and their therapeutic implications. | Cell Death Dis | 2024 | 38926399 | PubTator, text mining | PubMed |
| DcR3-associated risk score: correlating better prognosis and enhanced predictive power in colorectal cancer. | Discov Oncol | 2024 | 38890197 | PubTator, text mining | PubMed |
| KDM3A knockdown regulates COMP, LOX, COL8A1 and ACOT1 genes in myocardial fibrosis. | Bioinformation | 2024 | 38854759 | PubTator, text mining | PubMed |
| LncRNA-PCat19 acts as a ceRNA of miR-378a-3p to facilitate microglia activation and accelerate chronic neuropathic pain in rats by promoting KDM3A-mediated BDNF demethylation. | Mol Immunol | 2024 | 38643689 | PubTator, text mining | PubMed |
| Mitochondrial biogenesis in white adipose tissue mediated by JMJD1A-PGC-1 axis limits age-related metabolic disease. | iScience | 2024 | 38544573 | PubTator, text mining | PubMed |
| The molecular basis of cell memory in mammals: The epigenetic cycle. | Sci Adv | 2024 | 38416817 | PubTator, text mining | PubMed |
| Lysine demethylase 3A promotes chondrogenic differentiation of aged human dental pulp stem cells. | J Dent Sci | 2024 | 38303882 | PubTator, text mining | PubMed |
| Reprogramming of glucose metabolism: Metabolic alterations in the progression of osteosarcoma. | J Bone Oncol | 2024 | 38288377 | PubTator, text mining | PubMed |
| WNT/β-catenin regulatory roles on PD-(L)1 and immunotherapy responses. | Clin Exp Med | 2024 | 38280119 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55818/papers?page=4